Review

Ibrutinib for the treatment of chronic lymphocytic leukemia and mantle cell lymphoma.

Drugs Today. 2014 Apr 1;50(4):291-300.
Review

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765).

Leuk. Lymphoma. 2013 Nov 1;54(11):2385-91.
Multicenter Study

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

N. Engl. J. Med.. 2013 Jul 4;369(1):32-42.